Governance Changes

BIORA THERAPEUTICS, INC.: Amendment to certificate of incorporation to effect a 10:1 reverse stock split and reduce authorized shares from 300M to 255M, effective October 18, 2024 (effective 2024-10-18).

“To effect the Reverse Stock Split and the Authorized Shares Reduction, the Company filed an amendment to its Eighth Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware (the “ Amendment ”). As of the Effective Time, each 10 shares of Common Stock outstanding will be combined, automatically and without any action on the part of the Company or its stockholders, into one new share of Common Stock.”

STAR EQUITY HOLDINGS, INC.: Amended the restated certificate of incorporation to increase the number of authorized common shares and add preferred stock as an additional class of capital stock (effective 2024-10-11).

“On October 11, 2024, Star Equity Holdings, Inc. (the “Company”) filed an amendment to its Restated Certificate of Incorporation (the “Charter Amendment”) with the Secretary of State of the State of Delaware to increase the number of authorized shares of common stock, and to add shares of preferred stock as an additional class of capital stock.”

AiAdvertising, Inc.: Increased authorized number of shares of Series I Preferred Stock from 3,000,000 to 3,400,000 (effective 2024-10-09).

“On October 9, 2024, AiAdvertising, Inc. (the “Company”) filed a Certificate of Amendment with the Secretary of State of the State of Nevada (the “Certificate of Amendment”), thereby amending the Certificate of Designation of Preferences, Rights and Limitations of Series I Preferred Stock, as previously filed with the Secretary of State of the State of Nevada on April 10, 2023 (the “Certificate of Designation”). The Certificate of Amendment amended the Certificate of Designation to increase the authorized number of shares of Series I Preferred Stock from 3,000,000 to 3,400,000.”

RYDER SYSTEM INC: Amended By-Laws to update procedures for shareholder director nominations in connection with Universal Proxy Rules, including requiring representation of soliciting proxies from 67% voting power and providing that non-compliance renders nominations void (effective 2024-10-09).

“On October 9, 2024, the Board of Directors of Ryder System, Inc. (the “Company”) adopted amendments to the Company’s By-Laws (the “By-Laws”), effective as of that date, to make certain changes primarily in connection with Rule 14a-19 promulgated under the Securities Exchange Act of 1934, as amended (the “Universal Proxy Rules”), as part of its periodic review of corporate governance matters. As amended, the By-Laws now, among other things: (a) include certain updated procedures in connection with shareholder nominations of directors, including requiring a shareholder’s nomination notice to include a representation that such shareholder intends to solicit proxies from shareholders representing at least 67% of the voting power of shares entitled to vote on the election of directors, (b) provide that if a nominating shareholder fails to comply with the Universal Proxy Rules or fails to provide reasonable evidence of compliance with the Universal Proxy Rules, such shareholder’s proposed no”

Eaton Vance Municipal Income Trust: The Board adopted Amendment No. 1 to the By-Laws to eliminate the Control Share Provisions and make certain related conforming changes (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance California Municipal Income Trust: Eliminated Control Share Provisions and made related conforming changes in the By-Laws (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

QDM International Inc.: Amended articles of incorporation to increase authorized Series B Preferred Stock from 2,000,000 to 10,000,000 shares (effective 2024-10-04).

“On October 4, 2024, the Company filed an Articles of Amendment to Articles of Incorporation of the Company (the “Amendment”) with the Florida Division of Corporation to increase the Company’s authorized number of Series B Shares from 2,000,000 shares to 10,000,000 shares.”

Ares Management Corp: Filed Certificate of Designations to establish Series B Mandatory Convertible Preferred Stock (effective 2024-10-10).

“the Company filed a Certificate of Designations (the “Certificate of Designations”) with the Delaware Secretary of State on October 10, 2024, to establish the designations, powers, preferences and rights of the Series B Mandatory Convertible Preferred Stock and the qualifications, limitations and restrictions thereof. The Certificate of Designations became effective upon such filing.”

Eaton Vance Municipal Bond Fund: Eliminated Control Share Provisions and made related conforming changes to the By-Laws (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance California Municipal Bond Fund: Eliminated Control Share Provisions and made conforming changes to the By-Laws (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance New York Municipal Bond Fund: Eliminated Control Share Provisions from the By-Laws and made related conforming changes (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Ltd Duration Income Fund: Eliminated Control Share Provisions and made conforming changes (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 2 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Tax-Advantaged Dividend Income Fund: Eliminated Control Share Provisions from the By-Laws and made related conforming changes (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Senior Floating-Rate Trust: Eliminated the Control Share Provisions from the By-Laws and made related conforming changes (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 2 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Tax-Advantaged Global Dividend Income Fund: Eliminated Control Share Provisions and made related conforming changes to the By-Laws (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund: Eliminated Control Share Provisions from the By-Laws and made related conforming changes (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Short Duration Diversified Income Fund: Eliminated the Control Share Provisions from the By-Laws and made conforming changes (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Floating-Rate Income Trust: Amendment No. 3 to the By-Laws formally eliminating the Control Share Provisions and making conforming changes (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 3 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Enhanced Equity Income Fund: The Board adopted Amendment No. 1 to the By-Laws to eliminate Control Share Provisions and make related conforming changes (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund: Eliminated Control Share Provisions and made related conforming changes (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Tax-Managed Buy-Write Opportunities Fund: Eliminated Control Share Provisions and made related conforming changes via Amendment No. 1 to the By-Laws (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Tax-Managed Diversified Equity Income Fund: The Board adopted Amendment No. 1 to eliminate Control Share Provisions and make conforming changes (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Tax-Managed Global Diversified Equity Income Fund: Eliminated Control Share Provisions and made related conforming changes (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance Risk-Managed Diversified Equity Income Fund: Eliminated the Control Share Provisions from the Fund's Amended and Restated By-Laws and made related conforming changes (effective 2024-10-10).

“On January 26, 2023, the Board of Trustees of the Fund (the “Board”) voted to exempt, on a going forward basis, all prior and, until further notice, new acquisitions of Fund shares that otherwise might be deemed “Control Share Acquisitions” under the Fund’s Amended and Restated By-Laws (the “By-Laws”) from the provisions of the By-Laws addressing “Control Share Acquisitions” (the “Control Share Provisions”). On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

Eaton Vance National Municipal Opportunities Trust: Eliminated the Control Share Provisions and made conforming changes to the By-Laws (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

FiEE, Inc.: Increased designated Series A Convertible Preferred Stock from 2,000,000 to 3,000,000 (effective 2024-10-08).

“On October 8, 2024, Minim, Inc. (the “Company”) filed an amended and restated certificate of designation increasing its designated Series A Convertible Preferred Stock from 2,000,000 to 3,000,000.”

Eaton Vance Municipal Income 2028 Term Trust: Eliminated Control Share Provisions and made conforming changes to the By-Laws (effective 2024-10-10).

“On October 10, 2024, the Board adopted Amendment No. 1 to the By-Laws to formally eliminate the Control Share Provisions and to make certain related conforming changes.”

General Motors Co: Removed requirement that a proxy access shareholder nominee must provide an irrevocable resignation letter subject to certain conditions; also made administrative and clarifying updates (effective 2024-10-04).

“On October 4, 2024, the Board of Directors (the “Board”) of General Motors Company (the “Company”) approved amendments to the Company’s Bylaws (the “Amended and Restated Bylaws”), which became effective immediately.”

BIOREGENX, INC.: Filed Certificate of Designation to ratify creation and issuance of 5,000,000 Series A preferred shares with voting rights of 2,500 votes per share (effective 2024-03-14).

“Effective March 14, 2024, the Registrant filed a Certificate of Designation (and subsequently, a Certificate of Correction) curing the 2013 creation of the Series A preferred shares and ratifying the issuances of 5,000,000 Series A preferred shares in 2013 which were retired pursuant to the terms of the merger. Each Series A preferred share has voting rights of 2,500 votes per Series A preferred share.”

BIOREGENX, INC.: Increased authorized common stock to 1.5 billion shares and changed company name to BioRegenx, Inc (effective 2024-03-08).

“Effective March 8, 2024, the Registrant filed an Amendment to the Articles of Incorporation which increased the authorized common stock to One Billion Five Hundred Thousand (1,500,000,000) common shares. Additionally, the name of the Registrant was changed to BioRegenx, Inc.”

Celcuity Inc.: Approval of an amendment to the Certificate of Incorporation to increase the number of authorized shares of Common Stock from 65,000,000 to 95,000,000 (effective 2024-10-07).

“On October 7, 2024, Celcuity Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”) at which the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to increase the authorized number of shares of the Company’s Common Stock from 65,000,000 to 95,000,000 (the “Authorized Share Increase”). The Authorized Share Increase had previously been approved, subject to stockholder approval, by the Company’s Board of Directors. On October 7, 2024, the Company filed a certificate of amendment to the Certificate of Incorporation (the “Certificate of Amendment”) with the Delaware Secretary of State to effect the Authorized Share Increase, which became effective immediately upon its filing.”

INTERNET SCIENCES INC.: Amendment to Articles of Incorporation converting all issued and outstanding Class B Shares into Class A Shares (effective 2024-09-27).

“On September 27, 2024, the "Registrant filed an amendment to its Articles of Incorporation with the Delaware Secretary of State. This amendment effectuates the conversion of all issued and outstanding Class B Shares of the Registrant into Class A Shares.”

Onconetix, Inc.: Amended Certificate of Incorporation to effect a 1-for-40 reverse stock split of common stock (effective 2024-09-24).

“On September 23, 2024, the Company filed an amendment (the “ Amendment ”) to the Company’s Amended and Restated Certificate of Incorporation to effect a Reverse Stock Split of all of the outstanding shares of its issued and outstanding Common Stock at a ratio of one-for-forty (1:40). The Reverse Stock Split became effective in accordance with the terms of the Amendment at 12:01 a.m. Eastern Time on September 24, 2024 (the “ Effective Time ”).”

Innventure, Inc.: Learn CW and Holdco ceased to be shell companies upon consummation of business combination (effective 2024-10-02).

“On October 2, 2024, as a result of the consummation of the Business Combination, each of Learn CW and Holdco ceased to be a shell company.”

Innventure, Inc.: Adopted new Code of Conduct effective October 2, 2024 (effective 2024-10-02).

“on October 2, 2024, the Board approved and adopted a new code of conduct applicable to all employees, officers and directors of the Company (the “Code of Conduct”).”

Innventure, Inc.: Adopted Amended and Restated By-laws effective October 2, 2024 (effective 2024-10-02).

“By-laws of Innventure, Inc. (as amended and restated, the “By-laws”)”

Innventure, Inc.: Adopted Amended and Restated Certificate of Incorporation effective October 2, 2024 (effective 2024-10-02).

“adopted the Amended and Restated Certificate of Incorporation of Innventure, Inc. (as amended and restated, the “Charter”)”

Launch Two Acquisition Corp. reported a charter amendment (effective 2024-10-07).

“On October 7, 2024, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on October 7, 2024.”

TELLURIAN INC. /DE/: Amended and restated the bylaws in their entirety.

“Immediately after the Effective Time, the Company’s bylaws were amended and restated in their entirety by action of the Company’s board of directors.”

TELLURIAN INC. /DE/: Amended and restated the certificate of incorporation in its entirety.

“the certificate of incorporation of the Company was amended and restated in its entirety”

HMN FINANCIAL INC: Company's certificate of incorporation and bylaws replaced by Alerus' governing documents upon merger.

“As stated above, at the Effective Time, the separate corporate existence of the Company ceased and Alerus continued as the surviving corporation. In accordance with the Merger Agreement, the Certificate of Incorporation of the surviving corporation was Alerus’ Certificate of Incorporation, as amended, and the Bylaws of the surviving corporation were Alerus’ Bylaws, as amended.”

FlexShopper, Inc.: Increased authorized shares of common stock from 40,000,000 to 100,000,000 by filing a Certificate of Amendment to the Certificate of Incorporation (effective 2024-10-07).

“On October 7, 2024, FlexShopper, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Certificate of Incorporation (the “Charter”) with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), from 40,000,000 shares to 100,000,000 shares.”

OnKure Therapeutics, Inc.: Reneo ceased to be a shell company as a result of the Transactions.

“As a result of the Transactions, Reneo ceased to be a shell company (as defined in Rule 12b-2 of the Exchange Act) upon the Closing.”

OnKure Therapeutics, Inc.: Adoption of a new Code of Business Conduct and Ethics applicable to all employees, officers and directors.

“In connection with the Transactions, the Board approved and adopted a new Code of Business Conduct and Ethics applicable to all employees, officers and directors of the Company.”

OnKure Therapeutics, Inc.: Amendment and restatement of bylaws updating stockholder meeting procedures, director nomination requirements, board meeting provisions, indemnification, and other updates (effective 2024-10-04).

“On October 4, 2024, in connection with the Merger, the Board approved the amendment and restatement of the Company’s bylaws, effective as of October 4, 2024”

OnKure Therapeutics, Inc.: Amended and restated certificate of incorporation to change name to OnKure Therapeutics, Inc., create Class B Common Stock, reclassify Reneo common stock as Class A Common Stock (effective 2024-10-04).

“The amended and restated certificate of incorporation became effective at 4:02 p.m. on October 4, 2024.”

Cue Biopharma, Inc.: Increased authorized shares of capital stock from 110,000,000 to 210,000,000 and authorized shares of common stock from 100,000,000 to 200,000,000 (effective 2024-10-08).

“On October 8, 2024, Cue Biopharma, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware effecting an amendment to increase the number of authorized shares of the Company’s capital stock from 110,000,000 to 210,000,000 and increase the number of authorized shares of the Company’s common stock from 100,000,000 to 200,000,000.”

LanzaTech Global, Inc.: Amendment to increase authorized shares of common stock from 400,000,000 to 600,000,000 (effective 2024-10-03).

“At a Special Meeting of Stockholders of LanzaTech Global, Inc. (the “Company”), held on October 2, 2024 (the “Special Meeting”), and as further described in Item 5.07 below, upon the recommendation of the Company’s Board of Directors (the “Board”), the Company’s stockholders voted on and approved an amendment (the “Amendment”) to the Company’s Second Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to increase the number of authorized shares of common stock from 400,000,000 shares to 600,000,000 shares.”

Unusual Machines, Inc.: Amended and restated bylaws to change stockholder meeting quorum to one third of voting power and add timelines for stockholder proposals (effective 2024-10-03).

“On October 3, 2024, the Board of the Company approved and adopted amended and restated bylaws (the “Amended and Restated Bylaws”) which became effective on October 3, 2024.”

RenX Enterprises Corp.: Certificate of Amendment to Amended and Restated Certificate of Incorporation to effect a 1-for-20 reverse stock split (effective 2024-10-08).

“the Company filed a Certificate of Amendment (the “Amendment”) to the Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to effect the reverse stock split, with an effective time (the “Effective Time”) of 12:01 a.m. Eastern Time on October 8, 2024 (the “Reverse Stock Split”).”